Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rezatapopt

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update
    PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926889/0/en/PMV-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Progress-Update-on-PYNNACLE-Clinical-Trial.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator
    Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2889690/0/en/Foundation-Medicine-and-PMV-Pharma-Announce-Collaboration-to-Develop-Companion-Diagnostic-for-Rezatapopt-a-First-In-Class-Investigational-Selective-p53-Y220C-Reactivator.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share
    Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator
    Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator

    29 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240529460179/en

    BUSINESSWIRE
    29 May 2024
    Share Share